Lv5
1480 积分 2024-04-21 加入
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
5天前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
27天前
已完结
Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study
1个月前
已完结
A Prospective, Two Arm, Randomized Single Centre, Comparative Study to Evaluate Efficacy and Safety of Obeticholic Acid and Saroglitazar in Patients of Non- alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)
2个月前
已完结
The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials
2个月前
已完结
Targeting CDK4 and CDK6 in cancer
2个月前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
3个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
3个月前
已完结
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
4个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
4个月前
已完结
皖公网安备34019202002308
